沂蒙品牌怎么样 申请店铺

我要投票 沂蒙在玻璃胶行业中的票数:369 更新时间:2025-06-23
沂蒙是哪个国家的品牌?「沂蒙」是 山东省药用玻璃股份有限公司 旗下著名品牌。该品牌发源于山东省淄博市,由创始人扈永在1993-11-08期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力沂蒙品牌出海!将品牌入驻外推网,定制沂蒙品牌推广信息,可以显著提高沂蒙产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

沂蒙怎么样

山东省药用玻璃股份有限公司位于山东省沂源县城,这里是中国药用玻璃工业发源地之一,也是中国玻璃工业发达的地区。

山东省药用玻璃股份有限公司创立于1970年,以医药、食品、日用品行业为服务对象,生产各种药用、食品、日用品包装材料。2002年1月24日经中国证监会核准发行3200万股A股,并于2002年6月3日挂牌交易。

经过近40年的奋力拼搏,使山东药玻一步步成长为闻名世界的药用包装行业企业,产品市场覆盖32个省、市、自治区,并远销欧、美、俄、日、韩、东南亚等60多个国家和地区,每年为制药、食品、化妆工业提供百亿支各种规格的包装产品,这些产品中有模制抗生素瓶系列产品、管制瓶系列产品、棕色瓶系列产品、中性硼硅玻璃系列产品、输液瓶系列产品、日化瓶系列产品、食品瓶瓷砖 系列产品、丁基橡胶塞系列产品、预灌封注射器系列产品、铝塑盖系列产品、塑料瓶系列产品等,适用于制药工业粉针、水针、输液、口服液、冻干、生物制剂、片剂等不同药品制剂及食品、化妆品的包装需要,并有各种材质、瓶型及规格可供选择。其中公司的主导产品模制抗生素瓶年产量达90多亿支,药用丁基橡胶塞年产量48亿支,销往国内外各制药企业。

此外,山东药玻不断加大投入,采用最新科技,提高制造系列的自动化程度,完善生产工艺和质量控制手段,开发新的品种。引进了美国艾姆哈特行列式制瓶机生产线,实现了产品的自动检验和自动包装,提高了玻璃制品的成品率。强大的技术开发能力,不断满足用户的新需求成为可能。公司已现有科技成果172项,专利技术49项。

积40年从事药用玻璃制造的丰富经验和雄厚实力,山东药玻建立了完善的质量保证体系,对玻璃制造的每一个环节进行了严格的控制,在同行业中率先通过质量体系认证、环境体系认证和安全体系认证,并始终持续的改进保证体系,提升产品的品质,从而取得了和医药工业良好的配合,赢得了医药界人士的认可和赞赏。

Shandong Pharmaceutical Glass Co., Ltd. is located in Yiyuan County, Shandong Province, which is one of the birthplaces of China's pharmaceutical glass industry and the developed area of China's glass industry. Shandong Pharmaceutical Glass Co., Ltd. was founded in 1970, with the pharmaceutical, food, daily necessities industry as the service object, to produce a variety of pharmaceutical, food, daily necessities packaging materials. On January 24, 2002, China Securities Regulatory Commission approved the issuance of 32 million a shares, which was listed for trading on June 3, 2002. After nearly 40 years of hard work, Shandong Pharmaceutical glass has gradually grown into a world-famous pharmaceutical packaging industry enterprise. Its product market covers 32 provinces, cities and autonomous regions, and is exported to more than 60 countries and regions such as Europe, the United States, Russia, Japan, South Korea, Southeast Asia, etc. every year, it provides tens of billions of packaging products of various specifications for pharmaceutical, food and cosmetic industries, among which there are model antibiotics Bottle series products, control bottle series products, brown bottle series products, neutral borosilicate glass series products, infusion bottle series products, daily chemical bottle series products, food bottle ceramic tile series products, butyl rubber plug series products, pre filling syringe series products, aluminum plastic cover series products, plastic bottle series products, etc., suitable for powder injection, water injection, infusion, oral liquid in pharmaceutical industry , freeze-drying, biological agents, tablets and other different pharmaceutical preparations, food and cosmetics packaging needs, and a variety of materials, bottle types and specifications to choose from. Among them, the annual output of the company's leading product molding antibiotic bottles is more than 9 billion, and the annual output of medical butyl rubber plugs is 4.8 billion, which are sold to various pharmaceutical enterprises at home and abroad. In addition, Shandong Pharmaceutical glass has continuously increased investment, adopted the latest technology, improved the automation level of manufacturing series, improved production process and quality control means, and developed new varieties. The production line of American Emhart determinant bottle making machine is introduced to realize the automatic inspection and packaging of products and improve the yield of glass products. It is possible to continuously meet the new needs of users with powerful technology development capabilities. The company has 172 scientific and technological achievements and 49 patented technologies. With 40 years of rich experience and strong strength in pharmaceutical glass manufacturing, Shandong Pharmaceutical glass has established a perfect quality assurance system, strictly controlled every link of glass manufacturing, took the lead in the industry in passing the quality system certification, environmental system certification and safety system certification, and constantly improved the assurance system to improve the quality of products, so as to achieve and The good cooperation of the pharmaceutical industry has won the recognition and appreciation of the people in the pharmaceutical industry.

本文链接: https://brand.waitui.com/3548a554a.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

*ST星光:终止收购“造价通”平台资产及合作事项

36氪获悉,*ST星光公告,公司与广东中建普联科技股份有限公司于2025年6月23日签订《合资协议》之补充协议,决定终止收购“造价通”平台资产及有关“造价通”业务的相关合作事项。此次终止系公司与各方友好协商后的决定,合资公司尚未实缴出资,相关合作事项终止不会对公司正常经营及财务状况造成不利影响。

60分钟前

广州:目标到2027年L2(含)以上级别智能网联汽车新车占比超90%

36氪获悉,广州市人民政府办公厅印发《广州市推动智能网联新能源汽车产业发展三年行动计划》,目标到2027年,全市汽车产业转型升级初见成效,智能网联新能源汽车规模不断壮大,培育2—3家新能源汽车年产量超50万辆的汽车企业,整车与零部件产值比达1:0.6,整车及关键零部件品牌影响力大幅提升,核心技术创新能力全国领先。电动汽车基础设施日益完善,燃料电池汽车实现初步商业化应用。智能网联汽车方面,L2(含)以上级别智能网联汽车新车占比超90%,积极开放应用场景,推动自动驾驶规模化示范应用、示范运营。强化广深联动,力争实现粤港澳大湾区核心区域互联互通。

60分钟前

上周新增IPO受理企业20家

36氪获悉,据上交所企业上市服务消息,上周(6月16日—6月22日)新增IPO受理企业20家,其中上交所主板1家,科创板3家,深交所主板2家,创业板4家,北交所10家。截至6月22日,今年新增IPO受理企业61家。各板块在审企业共208家。其中上交所52家(主板27家,科创板25家),深交所45家(主板23家,创业板22家),北交所111家。

60分钟前

于东来称将关闭多家胖东来门店,工作人员回应:以公司官方通告为准

据报道,近日,胖东来创始人于东来开启直播,在直播中他再次明确将关闭多家胖东来门店,包括生活广场、人民路店、五一路店等。提及闭店原因时,于东来称这些店的经营都很好,但因这些老店、小店的品质已经跟不上了,所以选择逐步关掉。胖东来生活广场店工作人员对此表示,相关消息以公司官方通告为准。胖东来人民路店工作人员表示,目前没有收到相关闭店通知,即使店铺关闭,除某些特殊品类外售后服务仍可在其他店铺进行。(界面)

1小时前

海联讯:换股吸收合并杭汽轮事项申请获深交所受理

36氪获悉,海联讯公告,公司与杭汽轮B正在筹划由海联讯向杭汽轮全体换股股东发行A股股票的方式换股吸收合并杭汽轮,海联讯为吸收合并方,杭汽轮为被吸收合并方。6月20日,公司收到深交所出具的《关于受理杭州海联讯科技股份有限公司换股吸收合并杭州汽轮动力集团股份有限公司申请文件的通知》。深交所根据相关规定对申请文件进行了核对,认为申请文件齐备,决定予以受理。

2小时前

本页详细列出关于沂蒙的品牌信息,含品牌所属公司介绍,沂蒙所处行业的品牌地位及优势。
咨询